73 related articles for article (PubMed ID: 10208648)
1. Modified ligand binding to the naturally occurring Cys-124 variant of the human serotonin 5-HT1B receptor.
Brüss M; Bönisch H; Bühlen M; Nöthen MM; Propping P; Göthert M
Pharmacogenetics; 1999 Feb; 9(1):95-102. PubMed ID: 10208648
[TBL] [Abstract][Full Text] [Related]
2. Decreased agonist, but not antagonist, binding to the naturally occurring Thr92Lys variant of the h5-HT7(a) receptor.
Brüss M; Kiel S; Bönisch H; Kostanian A; Göthert M
Neurochem Int; 2005 Aug; 47(3):196-203. PubMed ID: 15896881
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological properties of the naturally occurring Phe-124-Cys variant of the human 5-HT1B receptor: changes in ligand binding, G-protein coupling and second messenger formation.
Kiel S; Brüss M; Bönisch H; Göthert M
Pharmacogenetics; 2000 Oct; 10(7):655-66. PubMed ID: 11037806
[TBL] [Abstract][Full Text] [Related]
4. Agonistic properties of alniditan, sumatriptan and dihydroergotamine on human 5-HT1B and 5-HT1D receptors expressed in various mammalian cell lines.
Lesage AS; Wouters R; Van Gompel P; Heylen L; Vanhoenacker P; Haegeman G; Luyten WH; Leysen JE
Br J Pharmacol; 1998 Apr; 123(8):1655-65. PubMed ID: 9605573
[TBL] [Abstract][Full Text] [Related]
5. 5-Hydroxytryptamine-induced contraction of human temporal arteries coexpressing 5-HT2A receptors and wild-type or variant (Phe124Cys) 5-HT1B receptors: increased contribution of 5-HT1B receptors to the total contractile amplitude in arteries from Phe124Cys heterozygous individuals.
Verheggen R; Werner I; Lücker A; Brüss M; Göthert M; Kaumann AJ
Pharmacogenet Genomics; 2006 Aug; 16(8):601-7. PubMed ID: 16847428
[TBL] [Abstract][Full Text] [Related]
6. Benzylimidazolines as h5-HT1B/1D serotonin receptor ligands: a structure-affinity investigation.
Law H; Dukat M; Teitler M; Lee DK; Mazzocco L; Kamboj R; Rampersad V; Prisinzano T; Glennon RA
J Med Chem; 1998 Jun; 41(13):2243-51. PubMed ID: 9632357
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological characterization of tegaserod at the wild type and 124Cys variant of the human 5-HT1B receptor.
Haenisch B; Bönisch H
Pharmacogenet Genomics; 2011 Jul; 21(7):432-5. PubMed ID: 21478802
[TBL] [Abstract][Full Text] [Related]
8. Genetic variation in human 5-HT receptors: potential pathogenetic and pharmacological role.
Göthert M; Propping P; Bönisch H; Brüss M; Nöthen MM
Ann N Y Acad Sci; 1998 Dec; 861():26-30. PubMed ID: 9928235
[TBL] [Abstract][Full Text] [Related]
9. Cloning, expression and pharmacology of a truncated splice variant of the human 5-HT7 receptor (h5-HT7b).
Jasper JR; Kosaka A; To ZP; Chang DJ; Eglen RM
Br J Pharmacol; 1997 Sep; 122(1):126-32. PubMed ID: 9298538
[TBL] [Abstract][Full Text] [Related]
10. The human serotonin 7 (5-HT7) receptor gene: genomic organization and systematic mutation screening in schizophrenia and bipolar affective disorder.
Erdmann J; Nöthen MM; Shimron-Abarbanell D; Rietschel M; Albus M; Borrmann M; Maier W; Franzek E; Körner J; Weigelt B; Fimmers R; Propping P
Mol Psychiatry; 1996 Nov; 1(5):392-7. PubMed ID: 9154233
[TBL] [Abstract][Full Text] [Related]
11. Chimeric receptor analysis of the ketanserin binding site in the human 5-Hydroxytryptamine1D receptor: importance of the second extracellular loop and fifth transmembrane domain in antagonist binding.
Wurch T; Colpaert FC; Pauwels PJ
Mol Pharmacol; 1998 Dec; 54(6):1088-96. PubMed ID: 9855638
[TBL] [Abstract][Full Text] [Related]
12. 2-(1-Naphthyloxy)ethylamines with enhanced affinity for human 5-HT1D beta (h5-HT1B) serotonin receptors.
Ismaiel AM; Dukat M; Law H; Kamboj R; Fan E; Lee DK; Mazzocco L; Buekschkens D; Teitler M; Pierson ME; Glennon RA
J Med Chem; 1997 Dec; 40(26):4415-9. PubMed ID: 9435911
[TBL] [Abstract][Full Text] [Related]
13. The binding of propranolol at 5-hydroxytryptamine1D beta T355N mutant receptors may involve formation of two hydrogen bonds to asparagine.
Glennon RA; Dukat M; Westkaemper RB; Ismaiel AM; Izzarelli DG; Parker EM
Mol Pharmacol; 1996 Jan; 49(1):198-206. PubMed ID: 8569707
[TBL] [Abstract][Full Text] [Related]
14. Activation of constitutive 5-hydroxytryptamine(1B) receptor by a series of mutations in the BBXXB motif: positioning of the third intracellular loop distal junction and its G(o)alpha protein interactions.
Pauwels PJ; Gouble A; Wurch T
Biochem J; 1999 Oct; 343 Pt 2(Pt 2):435-42. PubMed ID: 10510311
[TBL] [Abstract][Full Text] [Related]
15. Characterization of human serotonin 1D and 1B receptors using [3H]-GR-125743, a novel radiolabelled serotonin 5HT1D/1B receptor antagonist.
Doménech T; Beleta J; Palacios JM
Naunyn Schmiedebergs Arch Pharmacol; 1997 Sep; 356(3):328-34. PubMed ID: 9303569
[TBL] [Abstract][Full Text] [Related]
16. The cloning and expression of an OK cell cDNA encoding a 5-hydroxytryptamine1B receptor.
Cerutis DR; Hass NA; Iversen LJ; Bylund DB
Mol Pharmacol; 1994 Jan; 45(1):20-8. PubMed ID: 8302276
[TBL] [Abstract][Full Text] [Related]
17. Impairment of signal transduction in response to stimulation of the naturally occurring Pro279Leu variant of the h5-HT7(a) receptor.
Kiel S; Bönisch H; Brüss M; Göthert M
Pharmacogenetics; 2003 Feb; 13(2):119-26. PubMed ID: 12563181
[TBL] [Abstract][Full Text] [Related]
18. Affinity of cyamemazine metabolites for serotonin, histamine and dopamine receptor subtypes.
Benyamina A; Arbus C; Nuss P; Garay RP; Neliat G; Hameg A
Eur J Pharmacol; 2008 Jan; 578(2-3):142-7. PubMed ID: 17936750
[TBL] [Abstract][Full Text] [Related]
19. SB-216641 and BRL-15572--compounds to pharmacologically discriminate h5-HT1B and h5-HT1D receptors.
Price GW; Burton MJ; Collin LJ; Duckworth M; Gaster L; Göthert M; Jones BJ; Roberts C; Watson JM; Middlemiss DN
Naunyn Schmiedebergs Arch Pharmacol; 1997 Sep; 356(3):312-20. PubMed ID: 9303567
[TBL] [Abstract][Full Text] [Related]
20. Characterization of phospholipase C activity at h5-HT2C compared with h5-HT2B receptors: influence of novel ligands upon membrane-bound levels of [3H]phosphatidylinositols.
Cussac D; Newman-Tancredi A; Quentric Y; Carpentier N; Poissonnet G; Parmentier JG; Goldstein S; Millan MJ
Naunyn Schmiedebergs Arch Pharmacol; 2002 Mar; 365(3):242-52. PubMed ID: 11882920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
